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Abstract
Background: Antimicrobials are used by poultry farmers in Vietnam as a tool to treat and prevent infectious diseases.
We aimed to determine the fraction of disease episodes likely to remain untreated due to the administration of
antimicrobials on non-susceptible pathogens in chicken flocks in the Mekong Delta of Vietnam. Weekly data on
antimicrobial use and clinical signs were collected from 88 randomly chosen chicken flocks over 124 full production
cycles (i.e. time between restocking flocks with day-old chicks and sale for slaughter). A naïve Bayes model was trained
to infer the probabilities of disease episodes having been caused by each of 24 pathogens, given the observed clinical
sign profile, and expert knowledge on their relative incidence.
Results: A total of 224 disease episodes were observed, of which 44.8% were attributed to viruses (95% CI 31.1–58.4%),
54.6% (CI 40.4–68.7%) to bacteria, and 0.6% (CI 0–1.7%) to a protozoan (Eimeria spp.). Antimicrobials were more
frequently administered on weeks with disease than on weeks without disease (43.3% vs. 17.8%; p < 0.001). A median
of 2 [IQR 0–4] antimicrobials were used by episode. The choice of specific antimicrobials was independent on whether
the flocks had disease clinical signs or not. Antimicrobials were not used in 30.3% of the episodes. The overall
probability that episodes were not effectively treated was 74.2, and 53.7% when discounting cases where the inferred
aetiology is viral. Considering only episodes where antimicrobials were given, these probabilities were 57.4 and 23.8%
respectively.
Conclusions: This study highlights untargeted use of antimicrobials on small-scale Vietnamese chicken farms, as well
as the limitations of antimicrobials as effective tools to control infectious diseases.
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Background
Resistance against antimicrobials (“antimicrobial resist-
ance”, AMR) in animal production has received a great
deal of attention in recent times, particularly given its
serious implications for human health [1–3]. Zoonotic
transmission of resistant organisms or AMR-encoding
genes may result from environmental exposure of
humans to livestock or its excreta, and/or from the
transmission of livestock-borne resistant bacteria/genes
through the food chain [4]. Antimicrobials are useful
tools to control infectious diseases in animal populations
[5]. Recently a consensus has built around the need to
restrict their use other than for strict therapeutic pur-
poses, in order to limit the emergence of antimicrobial
resistant bacteria [6]. AMR in bacterial pathogens is hy-
pothesized to reduce the effectiveness of antimicrobials
in livestock production systems leading to lower levels
of profitability and productivity of these systems [7].
With over 100 million tons of meat produced per year
(2014), chicken represents the second most common ani-
mal food commodity worldwide [8]. Antimicrobials are
extensively used in poultry farming, especially in low- and
middle-income countries (LMICs) [9]. Faced with an epi-
sode of disease in the flock, the administration of
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antimicrobials is likely to be ineffective when there is mis-
match between the chosen antimicrobials and the causa-
tive pathogens. This is expected when antimicrobials are
administered to treat diseases caused by (1) a non-target
organism (i.e. a virus, a fungus, or an intrinsically resistant
parasite or bacterial strain), or (2) bacterial organisms that
have acquired resistance to the antimicrobial. This is likely
to be a common situation where the aetiological agent is
not adequately diagnosed, and the choice of antimicrobial
is not based on diagnostic or antimicrobial susceptibility
testing results. Since veterinary diagnostics are normally
not available to small-scale farmers typical of many devel-
oping countries, the antimicrobial susceptibility patterns
of bacterial organisms is unknown, and choice of antimi-
crobials is mostly determined by their availability and cost.
Here we develop an original naïve Bayes model ap-
proach integrating clinical signs and weekly antimicro-
bial use (AMU) data from 124 chicken production cycles
in 88 small-scale farms of the Mekong delta, Vietnam,
allowing to estimate to what extent disease episodes are
not effectively treated. Ineffective treatments are ex-
pected to fail to treat the disease, leading to a cost due
not only to the treatment itself, but also to the loss of
production. Ineffective treatments are also likely to con-
tribute to increase the level of resistance in both com-
mensal and pathogenic bacteria. Our method makes full
use of available information from the literature and ex-
pert opinion in view of the considerable information
gaps on diagnostics and antimicrobial sensitivity test
(AST), which is often the case in LMICs. These are also
the countries that bear the greatest burden of AMR in-
fections [10]. There is unfortunately no way to validate
our method. However, since the whole approach is en-
tirely probabilistic, we were able to quantify and accu-
mulate sources of uncertainty along the different steps
of the analysis, building confidence intervals around our
final estimates. Thus, if not perfect, this method has the
advantage of being affordable whilst providing estimates
that take into account any uncertainties about the data.
Our method may not be useful to improve the situation
of a particular farm but it is likely to be of invaluable use
in giving recommendations for a local geographical level
(district of province).
Methods
Farm selection and on-farm data collection
Eighty-eight (88) small-scale farms raising meat chicken
flocks were randomly selected from the official census held
by the veterinary authorities of Dong Thap province (Me-
kong Delta, Vietnam) (Sub-Department of Animal Health
and Production, SDAHP) in the Cao Lanh and Thap Muoi
districts, as part of the “baseline” (observational) phase of a
research project [11]. All study farms restocked with 100–
2000 chickens for each cycle of production. The chickens
are predominantly of native breeds, with a growing period
of 3–5months. The farmers typically sell their birds to local
markets with limited household consumption, and their in-
puts, including day-old-chicks, are also sourced locally.
Farmers were provided with a structured diary and were
instructed to weekly record information including: (1) clin-
ical signs of disease in the flock: malaise (i.e. prostration,
unwillingness to move, ruffled feathers), respiratory distress
(sneezing, coughing, nasal/ocular discharge, difficult breath-
ing), diarrhoea (watery faeces), alterations of the central
nervous system (CNS) (ataxia, circling, torticollis), leg le-
sions, sudden death (i.e. death with no clinical signs); and
(2) use of antimicrobial drugs (commercial products).
Farmers were trained by SDAHP veterinarians on recogni-
tion of the six above-listed clinical signs, and were asked to
keep containers of all antimicrobial products used. For each
production cycle, farms were visited four times, during
which records in the farm’s diary were checked, and labels
of antimicrobial products used reviewed. Individual anti-
microbial active ingredients were entered into a dedicated
database through a web application. All visits and data
entry were carried out by trained veterinarians affiliated to
the SDAHP.
Expert opinion on disease frequency
Three veterinarians based in Southeast Asia with experi-
ence in poultry medicine were independently asked to
score the frequencies of 25 common chicken infectious
diseases in the region. These pathogens included 14 bac-
teria: Listeria monocytogenes, Avibacterium paragalli-
narum, Chlamydia psittaci, Clostridium perfringens,
Escherichia coli, Erysipelothrix rhusiopathiae, Gallibacter-
ium anatis, Mycoplasma gallisepticum, Ornithobacterium
rhinotracheale, Pasteurella multocida (acute and chronic
infections), Pseudomonas spp., Salmonella Gallinarum,
Salmonella Pullorum, Staphylococcus aureus; 9 viruses:
Avian Encephalomielitis virus, Highly Pathogenic Avian
Influenza (HPAI) virus, Avian Metapneumovirus, Chicken
Anaemia virus, Infectious Bursal disease (Gumboro) virus,
Infectious Bronchitis virus, Infectious Laryngotracheitis
virus, Marek’s disease virus, Newcastle disease virus; and 1
protozoarian parasite (Eimeria spp.). The scores of each
expert were then scaled to sum up 100, in order to pro-
duce values of relative frequency and the average of these
3 scorings was considered in the analysis. Because we dis-
tinguished between the acute and chronic infections
caused by Pasteurella multocida, we will refer to 25 “path-
ogens” instead of 24 in the rest of the article.
Aetiology and antimicrobial resistance data from the
literature
We reviewed standard veterinary textbooks on avian dis-
eases [12, 13] to compile a presence/absence matrix of the
6 above-listed clinical signs caused by the 25 above-listed
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pathogens. We added to this matrix age information, i.e.
whether the pathogens are reported for young (< 7week-
old) and old (> 6 week-old) individuals, producing a final
“aetiology” matrix of 25 (pathogens) rows and 6 (clinical
signs) plus 2 (young and old) columns (Fig. 1).
We used a recently published literature review on the
resistance of bacterial pathogens against antimicrobials
[14] to produce a “resistance” matrix of 25 (pathogens)
rows and n (drugs) where n was the total number of drugs
recorded during the study, see Fig. 2. Each cell of this
matrix contains values between 0 (fully susceptible) and 1
(fully resistant), quantifying the resistance of a pathogen
to an antimicrobial drug. Missing values from a given
drug/pathogen combination were imputed from the mean
of the values for the drugs of the same class and the same
pathogen when possible. When imputation was not pos-
sible (because absence of data on all the drugs of one
class), we considered the mean of the values given by the
three independent veterinarian experts.
Analysis
A “disease episode”, defined as a succession of weeks
during which clinical signs were reported, was consid-
ered out unit of analysis. In order to account for defi-
ciencies in detecting/reporting clinical signs on farm, we
assumed that single weeks without clinical signs but pre-
ceded and followed by weeks where clinical signs were
reported were all part of the same disease episode. A
disease episode was then characterized by the set of
clinical signs observed and the set of antimicrobials ad-
ministered during any week of the episode.
The analysis was then developed in two stages. The
first one consisted in inferring the aetiologies of disease
episodes from their sets of clinical signs, as well as the
aetiology matrix and the expert opinion data, using a
naive Bayes model framework [15]. The aetiology matrix
was used to train the model, and expert opinion data
was used as prior information. Note that here, in ab-
sence of diagnostic tests, the training phase did not in-
clude any validation step. The aetiology matrix from the
literature was the only source of information available to
train the model. Once trained, the model was applied to
the set of clinical signs of each disease episode in order
to derive a vector of 25 probabilities (adding up to 1),
each probability of that vector quantifying the relative
chance that the disease episode was caused by a particu-
lar pathogen. We used a Laplace correction factor of 1
in order to account for the fact that observed combina-
tions of clinical signs may not perfectly match any of the
combinations of the aetiology matrix. The successive
steps leading to the inference of aetiologies of disease
episodes are sketched in Fig. 1.
In the second stage of the analysis, for each disease
episode, the above-derived aetiology probabilities were
then used together with the set of antimicrobials used
during the episode and the resistance matrix in order to
derive the probability that the applied treatment was in-
effective for treating the disease. For that, the resistance
matrix was subsetted by column for the drugs used
Fig. 1 Inferring the aetiologies of diseases episodes. (1) A 25 × 8 presence/absence matrix of clinical signs (and age of infection) per pathogen
and the average relative prevalence scores from 3 independent veterinarian experts (top) are used to train a naive Bayes model (centre). (2) The
naive Bayes model is then used to convert, for each disease episode, clinical signs and age surveillance data (presence/absence, left) into a vector
of aetiology probabilities (right)
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during the disease episode. The minimal values by row
(i.e. for a given pathogen) were then computed, produ-
cing a vector column of 25 values for the 25 pathogens.
The values of this vector were weighted (element-wise
multiplications) by the values of the vector of aetiology
probabilities and then averaged, producing a probability
that the used antimicrobials are ineffective in treating
the disease. The successive steps leading to inference of
this probability are sketched in Fig. 2.
Results
Farms, production cycles and disease episodes
The 88 farms were followed to include a total of 124 full
production cycles (54 over one cycle, 32 over 2 cycles; 2
over 3 consecutive cycles). A total of 224 disease epi-
sodes were observed over all cycles. The median dur-
ation of one cycle of production was 18 [IQR 17–20]
weeks. Clinical signs were recorded in 116/124 (93.5%)
cycles of production. The median duration of disease ep-
isodes was 2 [IQR 1–4] weeks. Disease episodes spanned
a median of 22.7% [IQR 10.0–40.0] observation weeks.
The most common clinical signs reported were, in de-
creasing order, malaise (81.2% episodes), diarrhoea
(29.0%), respiratory distress (24.1%), sudden death
(15.2%), leg lesions (11.1%), and alteration of the CNS
(0.8%). The probability of disease markedly decreased
with the age of the flock (Fig. 3).
Inference of aetiological agents from observed clinical
signs
The most common types of clinical signs of the 25
poultry etiologic agents (“aetiology matrix”) are pre-
sented in Additional file 1: Table S1. There was reason-
able agreement between all three reviewers in their
scoring of disease by their relative frequency (r values
between 0.78 and 0.89) (Additional file 1: Fig. S1).
Results from the naïve Bayes model expressed as rela-
tive probability (by episode and by cycle of production)
are presented in Table 1. There was a very strong correl-
ation between the relative probability of each pathogen
expressed by week and by episode (r = 0.954; p < 0.001).
The model attributed 44.8% (95% CI 31.1–58.4%) epi-
sodes to viral pathogens, 54.6% (95% CI 40.4–68.7%) to
bacterial pathogens, and 0.6% (95%CI 0–1.7%) to
Eimeria spp. (Table 2). The bacterial infections most
commonly predicted were, in decreasing order: (1) Erysi-
pelothrix rhusiopathiae (probability per episode 0.079);
(2) Gallibacterium anatis (0.073); (3) Mycoplasma galli-
septicum (0.068); (4) Salmonella Pullorum (0.068), and
S. Gallinarum (0.043). The most commonly predicted
viral infections were, in decreasing order: (1) Infectious
Bursal disease (IBD) (0.162); (2) Avian Metapneumovirus
infection (0.105); (3) Marek’s disease (0.057); (4) Infec-
tious Laryngotracheitis (0.038); and (5) Newcastle dis-
ease (0.034) (Table 1). There was a strong positive
correlation between the probability attributed to a
Fig. 2 Computing the probability of treatment failure of disease episodes. (1) For each disease episode, we subset the resistance matrix with the
drugs used during the disease episode. (2) Then, for each pathogen of the subsetted matrix, we select the minimal level (min) of resistance
across the used drugs. (3) The resulting vector is weighted (element-wise multiplication) by the vector of aetiology probabilities computed for
that disease episode by the naive Bayes model (Fig. 1); and, (4) The mean of that weighted vector is used as the probability of treatment failure
in the disease episode
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bacterial pathogen and the duration of episodes (r =
0.37; p < 0.001).
Overall, there was a reasonable agreement between
the prior probabilities estimated by the naïve Bayes
model and the average of the three poultry veterin-
ary experts. However, the assessments of the experts
on HPAI, E. coli, Infectious Bronchitis virus, Avibac-
terium paragallinarum and Eimeria spp. are higher
than the incidences predicted by the model (Fig. 4).
Conversely, their assessments on Avian Metapneu-
movirus, G. anatis, E. rhusiopathiae, and Clamydia
psittaci are lower than the incidences predicted by
the model (Fig. 4).
Antimicrobial use and disease episodes
Antimicrobials were more frequently administered on
disease episode weeks (296/683, 43.3%), than in weeks
without disease (281/1582, 17.8%) (χ2 = 163.0, p = 0.001)
. Similar to the probability of disease, the weekly prob-
ability of antimicrobial usage decreased with the age of
the flock: from 0.84 (week 1), to 0.31–0.44 (weeks 2–7),
0.10–0.30 (weeks 8–15), and < 0.10 thereafter. Farmers
did not use antimicrobials in 88/224 (39.3%) of disease
episodes. Thirty-eight (38) different types of antimicro-
bials were used by farmers (Additional file 1: Table S2).
The most frequently used antimicrobials were: colistin
(12.2% weeks across farms), oxytetraycline (9.8%), tylosin
Fig. 3 Disease episodes of over the 124 full cycles of production. Top: prevalence of clinical signs of disease on farms (with 95% confidence
interval), by week. Bottom: production weeks with (red) and without (blue) disease episode
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(4.8%), and doxycycline (3.7%). These four antimicrobials
represented 53.1% of total usage. In episodes where anti-
microbials were used, the median number of different
antimicrobials used was 3 [IQR 2–4]. There was no evi-
dence that different antimicrobials are more likely to be
used in situations of disease, compared with no disease
(Fig. 5). Episodes where no antimicrobials were used
had a shorter duration (median 1 [IQR 1–2] weeks)
compared with episodes where antimicrobials were
used (median 3 [IQR 1–5] weeks) (Wilcoxon test,
W = 3120; p < 0.001).
Phenotypic resistance of bacterial organisms
The full list of antimicrobials used, alongside the preva-
lence of resistance of poultry pathogens against them is
presented in Additional file 1: Table S2.
Probability that disease in flocks remains untreated
The overall probability (all episodes) that a disease
episode remains untreated (either because of absence
of treatment, or because of ineffective treatment)
was 74.2% (95% CI 68.4–79.9%) for all episodes, and
53.7% (95% CI 47.2–60.3%) for episodes due to bac-
terial pathogens (including Eimeria spp.). For epi-
sodes where antimicrobials were given, the estimated
treatment failure was 57.4 (51.0–63.9%) (all patho-
gens), and 23.8% (95% CI 18.2–29.4%) (bacterial
pathogens). The probability of failing to treat the
disease in episodes where antimicrobials were given
was very variable, ranging from 0.423 (Ornithobac-
terium rhinotracheale) to 0.030 (Pasteurella multo-
cida) (Table 2). For bacterial pathogen, this
probability was strongly dependent on the number of
antimicrobials used (Fig. 6).
Table 1 Average probabilities (with 95% confidence intervals) of each of the pathogens (in row) to be the etiological cause of a
disease episode or a disease episode in a cycle of production. Note that the probabilities do not necessarily sum to 1 by row
because they are averages by episode and cycle of production. Note also that the probabilities averaged by episode can be
compared to the mean of the score of the 3 independent experts
Pathogen Episode Cycle of production
Model 95% CI Expert opinion Model 95% CI
Infectious Bursal Disease virus 0.162 0.113–0.210 0.101 0.303 0.101–0.506
Avian Metapneumovirus 0.105 0.064–0.145 0.014 0.194 0.044–0.345
Erysipelothrix rhusiopathiae 0.079 0.044–0.115 0.009 0.147 0.044–0.251
Gallibacterium anatis 0.073 0.039–0.107 0.008 0.137 0.030–0.244
Mycoplasma gallisepticum 0.068 0.035–0.101 0.074 0.127 0.029–0.225
Salmonella Pullorum 0.068 0.035–0.101 0.042 0.127 0.042–0.213
Marek’s Disease virus 0.057 0.026–0.087 0.059 0.105 0.000–0.219
Salmonella Gallinarum 0.043 0.016–0.069 0.028 0.080 0.028–0.133
Infectious Laringotracheitis virus 0.038 0.013–0.063 0.022 0.036 0.007–0.064
Clostridium perfringens (necrotic) enteritis) 0.038 0.013–0.063 0.059 0.071 0.004–0.138
Escherichia coli (colibacillosis) 0.034 0.011–0.058 0.106 0.063 0.023–0.102
Newcastle Disease virus 0.034 0.010–0.057 0.079 0.064 0.000–0.133
Chlamydia psittaci 0.034 0.010–0.057 0.006 0.063 0.016–0.111
Staphylococcus aureus 0.032 0.009–0.054 0.024 0.059 0.013–0.105
Chicken Anaemia virus 0.031 0.008–0.053 0.022 0.057 0.016–0.098
Pasteurella multocida (acute) (fowlcholera) 0.025 0.004–0.045 0.035 0.047 0.003–0.091
Ornithobacterium rhinotracheale 0.023 0.003–0.042 0.025 0.042 0.007–0.077
Listeria monocytogenes 0.012 0.000–0.026 0.009 0.022 0.000–0.043
Infectious Bronchitis virus 0.011 0.000–0.024 0.060 0.020 0.008–0.033
Avian Encephalomielitis virus 0.009 0.000–0.021 0.011 0.008 0.000–0.016
Avibacterium paragallinarum 0.008 0.000–0.020 0.031 0.015 0.000–0.032
Eimeria spp. 0.006 0.000–0.017 0.038 0.012 0.003–0.022
Pasteurella multocida (chronic) 0.005 0.000–0.015 0.011 0.010 0.000–0.020
Pseudomonas spp. 0.005 0.000–0.014 0.011 0.009 0.000–0.018
Highly Pathogenic Avian Influenza virus 0.002 0.000–0.008 0.113 0.004 0.000–0.011
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Table 2 Average probabilities (with 95% confidence intervals) that a disease episode caused by a given bacteria (by row) remains
untreated either because of absence of treatment or because of ineffective treatment (first two columns), or because of ineffective
treatment only (last two columns). The probabilities in the last two columns are necessarily smaller than in the first two columns
Bacterial pathogen Overall treatment failure Treatment ineffective when antimicrobial/s given
Mean 95% CI Mean 95% CI
Avibacterium paragallinarum 0.499 0.433–0.564 0.175 0.125–0.224
Chlamydia psittaci 0.554 0.488–0.619 0.265 0.207–0.322
Clostridium perfringens (necrotic enteritis) 0.595 0.530–0.659 0.332 0.271–0.394
Eimeria spp. 0.895 0.855–0.935 0.827 0.778–0.877
Erysipelothrix rhusiopathiae 0.611 0.547–0.675 0.360 0.297–0.422
Escherichia coli (colibacillosis) 0.555 0.490–0.620 0.266 0.209–0.324
Gallibacterium anatis 0.562 0.497–0.627 0.278 0.220–0.337
Listeria monocytogenes 0.602 0.538–0.666 0.344 0.282–0.406
Mycoplasma gallisepticum 0.645 0.582–0.707 0.415 0.350–0.479
Ornithobacterium rhinotracheale 0.650 0.587–0.712 0.423 0.359–0.488
Pasteurella multocida (acute (fowl cholera)) 0.411 0.347–0.475 0.030 0.008–0.052
Pasteurella multocida (chronic) 0.411 0.347–0.475 0.030 0.008–0.052
Pseudomonas spp. 0.479 0.413–0.544 0.142 0.096–0.187
Salmonella Gallinarum 0.425 0.360–0.490 0.053 0.024–0.082
Salmonella Pullorum 0.425 0.360–0.490 0.053 0.024–0.082
Staphylococcus aureus 0.472 0.407–0.537 0.130 0.086–0.175
Overall (all episodes) 0.537 0.472–0.603 0.238 0.182–0.294
Fig. 4 Relationship between prior estimates from veterinary expert
opinion and posterior probabilities predicted by the naïve Bayes
model. Lines above the diagonal have slopes increasing from 2
(black dashed line), 3, … 10, 20, …50 (all grey lines). Similarly, lines
below the diagonal have slopes decreasing from ½ (black dashed
line), 1/3, … 1/10, 1/20, … 1/50 (all grey lines)
Fig. 5 Probability of use of antimicrobial active ingredients in weeks
with and without disease. Relationship, for each antimicrobial,
between the probability of use during a week with disease and
without disease. The black line is the regression line and the light
and grey areas are the 99 and 95% confidence intervals respectively.
The dashed line is the expected relationship in case there is no
difference of usage between the weeks with and without disease
(the slope is equal to the ratio of weeks with and without disease).
cst = colistin, oxt = oxytetracycline, tyl = tylosin, dxc = doxycycline,
neo = neomycin, gen = gentamicin, str = streptomycin, amp =
ampicillin, amx = amoxicillin, gen = gentamicin, efx = enrofloxacin,
tmp = trimethoprim, smx = sulfamethoxazole,
ffc = florfenicol, tmp = thiamphenicol
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Discussion
Antimicrobials are formidable tools for the control of in-
fectious diseases in animal production. The trade-offs of
antimicrobial usage have been discussed, although focused
on their costs vs. the benefits from protecting flocks/herds
from disease [16]. This study is, to our knowledge, the first
one to look into the likelihood of unsuccessful treatment
of infectious diseases in small-scale farming systems in
Asia, either because antimicrobials were not used, or be-
cause an ineffective antimicrobial were used. Key findings
of this study are: (1) half (48.7%) antimicrobial use oc-
curred on weeks without disease; (2) for episodes where
antimicrobials were used, they were expected to be inef-
fective in 57.4% (CI 51.0–63.9%) episodes (for all patho-
gens considered), and 23.8% (18.2–29.4%) (for bacterial
pathogens); (3) antimicrobials were not used in over a
third (39%) of disease episodes.
Our analysis estimated that approximately a fourth
(23.8%) of treated bacterial episodes are likely to be inef-
fective due to the organisms treated being resistant to
the antimicrobials used. This outcome is likely a com-
bination of “intrinsic” and “acquired” resistance proper-
ties of bacterial pathogens. However, in this paper we
have not attempted to investigate the fraction likely due
to acquired resistance since for many antimicrobials and
pathogens this is now well known. Most published AMR
data on poultry pathogens comes from studies in devel-
oped countries. Given the higher levels of antimicrobial
use in Vietnamese chicken farms [17], it is likely that the
resulting values of expected antimicrobial resistance are
underestimated. We ignored the timing of application of
the antimicrobial in relation to the onset of disease, or
the order of the administration because this could not
be determined from weekly data collection. Surprisingly
however, in over a third of disease episodes (39%)
farmers gave no antimicrobials at all, resulting in an
even higher percent in overall failure to efficiently treat
a bacterial disease episode (53.7%). When viruses are
also considered, the overall fraction of treatment failure
reached 74.2%, as ~ 45% of disease episodes were ex-
pected to be caused by viral pathogens.
Two assumptions of our study may have resulted in
biased results. Firstly, the assumption that all disease ep-
isodes were either due to a bacterial or a viral pathogen,
excluding helminth infections and other non-infectious
aetiologies (i.e. toxicosis, metabolic disorders, etc.).
However, given the farming conditions of small-scale
farms in Vietnam, with generally serious deficiencies in
biosecurity, it is likely that the overwhelming majority of
over disease is infectious in nature. Secondly, the study
is necessarily biased towards diseases that are easier to
diagnose/detect. Interestingly the expert panel predicted
HPAI and colibacillosis (E. coli) to be more common
than what the model predicted after integrating data on
clinical signs. Further diagnostic testing in the area by
the authors has confirmed a lack of HPAI in the areas at
the time of the study (data not shown). Surprisingly, the
model and the experts predicted generally relatively low
incidence of coccidiosis (Eimeria spp.), which is
regarded as a major health problem in industrialised
poultry production systems. It is believed that coccidial
infectious are indeed present, but mostly the subclinical
form is predominant, contributing to reduced intestinal
functions [18]. Thirdly, we ignored data on vaccination
(mostly to prevent viral infections) and assumed that the
probability of an episode due to a given virus was not af-
fected by whether the flock had been vaccinated or not.
Farmers in the area apply vaccines notably against HPAI,
IBD and Newcastle disease. However, the application of
the vaccine requires careful logistics including adequate
strain choice and logistics (timing, booster, storage and
administration logistics) than more often than not were
Fig. 6 Predicted summary treatment failure of individual episodes attributed to bacterial pathogens. The box indicates median values and 75%
interquartile-range; whiskers indicate extreme values
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not met. In the case of HPAI, there is some evidence
that vaccination coverage is either low or application is
performed poorly [19].
A third of disease episodes did not trigger farmers to ad-
minister antimicrobials. These episodes were typically
short (one week) with non-specific signs of disease (i.e.
malaise). Often in these cases, farmers used vitamins, pro-
biotics, yeasts and antibodies to manage poultry health is-
sues (data not shown). Interestingly, episodes attributed to
bacteria tended to last longer, giving further empirical evi-
dence to the phenomenon of AMR on farms.
Although most episodes were addressed by the admin-
istration of two antimicrobials, in some instances up to
10 different antimicrobial active principles were used by
the farmer. This is not surprising, since many commer-
cial antimicrobial formulations in the area include at
least two antimicrobial active ingredients [20] and con-
firms high usage of antimicrobials in Vietnamese small-
scale chicken farms [20, 21]. However, over 50% of total
antimicrobial use corresponded to weeks with no disease
reported (i.e. prophylactic use). This is likely to be partly
triggered by fear of disease, either from previous experi-
ence or by the knowledge of presence of nearby disease,
coupled with the lack of competent veterinary diagnos-
tic/advisory capacity. As suggested in the introduction,
there is a strong suspicion that the choice of antimicro-
bials is currently based on costs.
Some of the most commonly used antimicrobials (i.e.
colistin, oxytetracycline) were associated with a high
probability of ineffective treatment of the disease (data
not shown). In the case of colistin, this reflects a high
predicted incidence of Gallibacterium anatis infection
(characterized by respiratory, diarrhoea and malaise, in
all ages), and Erysipelothrix rhusiopathiae (malaise, sud-
den death, in all ages), both of which are often very re-
sistant against these antimicrobials (≥40%). To the best
of our knowledge, Gallibacterium anatis has never been
isolated in Vietnam. Our results suggest that it could be
valuable to include this pathogen in the diagnostic test-
ing protocols. The use of colistin (and to lesser extent
fluoroquinolones, macrolides, aminoglycosides and β-
lactams), some of which are considered of critical im-
portance for human medicine [22] is particularly worry-
ing from a public health point of view.
Our approach is particularly useful in settings where
diagnostic capacity (and AMR testing) is limited, such as
many LMICs [23]. As more local epidemiological and
microbiological data becomes available, through improved
diagnostic and AMR testing, these can easily be integrated
in our modelling framework to improve the precision and
accuracy of our estimates. The approach can also help to
focus diagnostic efforts towards those diseases that are
considered more likely, as well as to review vaccination
programmes. In generally, the model framework we
developed here can be used for any system (animal or hu-
man) where clinical signs, antimicrobial use and AMR
data are known to improve treatment success.
In summary, using a novel integrated methodology that
combined data from expert opinion, literature and field
observations, we investigated the relationship between
AMU and infectious disease in smallholder poultry sys-
tems. When farmers used antimicrobials to address dis-
ease episodes in their flocks, failure to treat disease was
expected in about ~ 57% cases (~ 24% assuming a bacter-
ial causative agent). Our study shows a high frequency of
usage of antimicrobials in situations with no disease, and
absence of use when disease is present on flocks, the wide-
spread use of multiple courses of different antimicrobials,
and the random use of different antimicrobial products
suggesting that there is ample room for improvement in
the targeting of antimicrobials on farms in small-scale
farming systems in Vietnam.
Conclusions
This study shows how clinical signs and antimicrobials
usage surveillance data can be used to infer the level of
antimicrobial misuse in chicken farms. The naïve Bayes
framework that we employ allows to do so probabilistic-
ally, rigorously accounting for all sources of uncertainty.
Our results show that a vast majority of disease episodes
are likely to be not treated effectively, representing an
important loss for the farmers. The method that we de-
velop is general and can be applied to any set-up, includ-
ing human infections. The model can also be used to
improve the current treatments at use.
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